A radiotherapy dose of 12 Gy or greater to the left anterior descending coronary artery was associated with elevated risk for cardiotoxicity (HR=1.81). Among patients who received heart-sparing ...

The researchers designed this retrospective cohort study to examine the effect of demographics, including race/ethnicity, insurance status, age, and geographic location, on prostate cancer screening ...

Lung transplantation can prolong survival for select patients with medically refractory, lung-limited, stage IV non-small cell lung cancer (NSCLC), according to a study published online July 8 in the ...

In this systematic review, researchers aimed to analyze the uptake of breast cancer risk management strategies, including prophylactic mastectomy, intensive surveillance, or no active strategy, in ...

Investigators conducted this cross-sectional secondary analysis using baseline data from a phase 3 randomized controlled trial to explore associations between fear of cancer recurrence and coping ...

Investigators conducted a cross-sectional survey to identify factors associated with psychological hardship related to the ...

FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.

The odds of human papillomavirus (HPV)-related cancers are increased among people with HIV (PWH) and solid organ transplant recipients (SOTRs), according to a study published online June 30 in JAMA ...

Investigators compared the safety and efficacy of polatuzumab vedotin with or without rituximab, gemcitabine, and oxaliplatin in first line for patients with relapsed/refractory diffuse large B-cell ...

In this long-term follow-up to the phase 2 ARTO trial, researchers analyzed survival outcomes in patients with CRPC treated with metastasis-directed therapy.

In this analysis, researchers examined long-term outcomes for EWS survivors based on chemotherapy regimen, as well as compared to siblings and the general population.